Rosmanol Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Enhances Apoptosis, the Regulation of MAPK/NF‐κB Signaling Pathway
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2750 ↗At a glance
Journal article in Biotechnology and Applied Biochemistry, 2025. Written by Weiping Tao and 4 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, The Fourth Hospital of Changsha, Changsha, China. Major MEDLINE topics: NF-kappa B, Apoptosis, Nasopharyngeal Carcinoma, Cell Proliferation. Cited 4 times so far (Crossref); 43 references.
Abstract (original language)
Nasopharyngeal Carcinoma (NPC) is a major public health problem in endemic zones. NPC is correlated with substantial illness and death; thus, superior treatment is desired. Rosmanol (RM) is a phenolic diterpene antioxidant extracted from the medicinal herb Rosemary ( Rosmarinus officinalis ). RM has been investigated for its anti‐inflammatory and anti‐tumor properties by numerous signaling cascades. However, the fundamental anticancer latent mechanism of RM persists as unidentified. Hence, this present research proposes to search for the anti‐cancer efficacy of RM on human NPC cells CNE2 using an in vitro approach. To assess the possible molecular mechanisms of proliferation, apoptosis, cell‐cycle regulatory proteins, and MAPKs/NF‐κB signaling of NPC cells were administered RM (20 and 30 µM) and assayed through MTT, DCFH‐DA, Rh‐123 staining, AO/EB, PI, Rh‐123/DAPI merge form staining, RT‐PCR, and Western blot. The result was recognized that RM could reduce NPC cell viability by elevated intracellular ROS, MMP damage, and generate apoptosis. RM inhibits the Cyclin‐D1, Bax, TNF‐α, and NF‐κB, and induces BCl‐2 analyzed via RT PCR. RM attenuates the cell cycle mechanism by repressing NPC cell cycle‐related proteins: CDK4/CDK6, pRB, cyclin‐D1, and MAPKs/NF‐κB signaling. These data established that the MAPKs/NF‐κB pathway is a potential target for the remedial action of RM. In summary, RM may be an effective conventional chemotherapy drug in preventing the progression of NPC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otorhinolaryngology-Head and Neck Surgery, The Fourth Hospital of Changsha, Changsha, China.
- Department I of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming City, China.
- Galileovasan Offshore and Research and Development Pvt Ltd, Nagapattinam, Tamil Nadu, India.
- Department of Otolaryngology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
ORCID profiles: Weiping Tao, Cao Lv
Cite
APA
Tao, W., Jiang, C., Velu, P., Lv, C., & Niu, Y. (2025). Rosmanol Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Enhances Apoptosis, the Regulation of MAPK/NF‐κB Signaling Pathway. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2750
Vancouver
Tao W, Jiang C, Velu P, Lv C, Niu Y. Rosmanol Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Enhances Apoptosis, the Regulation of MAPK/NF‐κB Signaling Pathway. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2750
BibTeX
@article{Tao2025,
author = {Tao, Weiping and Jiang, Chaowu and Velu, Periyannan and Lv, Cao and Niu, Yan},
title = {Rosmanol Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Enhances Apoptosis, the Regulation of MAPK/NF‐κB Signaling Pathway},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2750}
}
EUVIMED